First, we determined the inhibitory effect of MRTX1719 on the growth and proliferation of MTAP‐deficient glioma cells (Hs683 and U‐118MG), MTAP‐normal glioma cells (GL261), MTAP‐normal microglial (HMC3), and neuronal cells (SH‐SY5Y) (Figure 5A). The gene discussed is MTAP; the disease is central nervous system cancer.